Electrochemical synthesis of selenyl imidazo[2,1-<i>b</i>]thiazinones <i>via</i> three-component reactions-Reference-Cited by-同舟云学术

Electrochemical synthesis of selenyl imidazo[2,1-b]thiazinones via three-component reactions

Published:2024 Issue: Volume: Page:
ISSN:2052-4129
Container-title:Organic Chemistry Frontiers
language:en
Short-container-title:Org. Chem. Front.

Author:

Yue Yuancheng¹,Chen Ziren¹^ORCID,Xue Fei¹,Wang Bin¹^ORCID,Zhang Yonghong¹^ORCID,Xia Yu¹^ORCID,Wu Shaofeng¹,Jin Weiwei²^ORCID,Liu Chenjiang¹^ORCID

Affiliation:

1. Urumqi Key Laboratory of Green Catalysis and Synthesis Technology, Key Laboratory of Oil and Gas Fine Chemicals, Ministry of Education & Xinjiang Uygur Autonomous Region, State Key Laboratory of Chemistry and Utilization of Carbon Based Energy Resources, College of Chemistry, Xinjiang University, Urumqi 830017, P. R. China

2. Key Laboratory of Specialty Agri-Product Quality and Hazard Controlling Technology of Zhejiang Province, College of Life Sciences, China Jiliang University, Hangzhou 310018, P. R. China

Abstract

In this paper, we have developed an efficient strategy for the concise synthesis of diverse selenyl imidazo[2,1-b]thiazinones via electrochemical oxidative three-component tandem reactions in the absence of transition metals, and oxidants.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/QO/D4QO01354A

Reference58 articles.

1. Construction of sulfur-containing moieties in the total synthesis of natural products

2. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals

3. Dual Targeting of Adenosine A2A Receptors and Monoamine Oxidase B by 4H-3,1-Benzothiazin-4-ones

4. Synthesis and docking study of diaryl-isothiazole and 1,2,3-thiadiazole derivatives as potential neuroprotective agents

5. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication